Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 22 January 2026

Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft shares fell 33% after the company announced a major restructuring and canceled six games, cutting its 2026 net bookings forecast to 1.5 billion euros and projecting a 1 billion euro operating loss. The company withdrew guidance for fiscal 2026/27. Trading paused at 4.6 euros per share, valuing Ubisoft at 616 million euros. Investors await further details at a Feb. 12 update.
22 January 2026
·
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.
22 January 2026
···
FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

Rothschild Redburn downgraded FedEx to Neutral and raised its price target to $317, citing the planned freight spin-off. Argus and Wolfe Research lifted their FedEx price targets to $350 and $355, respectively, while maintaining positive ratings. FedEx shares closed at $306.95, about 3.7% below their 52-week high. The company aims to complete the FedEx Freight spin-off by June 1, 2026.
22 January 2026
·
Diageo share price climbs in London as Barclays, Jefferies stick with Buy calls ahead of Feb 25 results

Diageo share price climbs in London as Barclays, Jefferies stick with Buy calls ahead of Feb 25 results

Diageo shares rose 0.5% in early London trading Thursday after a 2.6% gain the previous day, though the stock remains down 31% over the past year. The company reaffirmed its 2026 outlook, expecting flat or slightly lower organic net sales and low-to-mid single-digit profit growth. United Spirits, Diageo’s Indian arm, reported a 12% profit jump on strong premium sales. Interim results are due Feb. 25.
22 January 2026
·
LSEG share price dips in early London trade after fresh buyback update — here’s what investors are watching

LSEG share price dips in early London trade after fresh buyback update — here’s what investors are watching

London Stock Exchange Group shares slipped 0.5% to 8,736 pence by mid-morning Thursday after announcing a fresh buyback. The move followed a 2.2% drop Wednesday, underperforming the FTSE 100. Deutsche Boerse’s 5.35 billion euro Allfunds deal kept sector M&A in focus. Investors await the Bank of England’s Feb. 5 meeting and LSEG’s full-year results on Feb. 26.
22 January 2026
··
Lloyds shares are above £1 again — UBS lifts target as investors do the dividend maths

Lloyds shares are above £1 again — UBS lifts target as investors do the dividend maths

Lloyds shares rose 1.8% to 103.25p in early London trading, surpassing the £1 mark ahead of full-year results due Jan. 29. UBS raised its price target to 103p but kept a neutral rating, citing post-2026 growth uncertainty. Analyst consensus puts the 12-month target at 101.11p, below the current price. Retail investors are watching for dividend prospects, with forecasts suggesting only modest gains.
22 January 2026
··
GSK share price steadies as $2.2bn RAPT deal lands amid fresh U.S. vaccine-policy risk

GSK share price steadies as $2.2bn RAPT deal lands amid fresh U.S. vaccine-policy risk

GSK shares rose 0.1% in early London trading as investors assessed the $2.2 billion acquisition of RAPT Therapeutics and changes to ViiV Healthcare’s ownership. The deal brings ozureprubart, a mid-stage food-allergy drug, into GSK’s pipeline. Pfizer will exit ViiV, with Shionogi raising its stake to 21.7%. Uncertainty over U.S. vaccine policy clouds the outlook ahead of GSK’s Feb. 4 results.
22 January 2026
···
Barclays snaps up 2.5 million more shares as buyback presses on amid tariff volatility

Barclays snaps up 2.5 million more shares as buyback presses on amid tariff volatility

Barclays bought back 2,522,940 shares on Jan. 21 at an average price of 475.07 pence, bringing total repurchases since October to 86,403,909 shares. All repurchased shares will be cancelled, reducing the bank’s share capital to 13.83 billion ordinary shares. The buybacks come amid renewed tariff disputes and geopolitical tensions affecting markets. NatWest also repurchased 830,691 shares for cancellation on Wednesday.
22 January 2026
··
BP buyback update nudges shares higher as oil slips and tariff talk shadows the sector

BP buyback update nudges shares higher as oil slips and tariff talk shadows the sector

BP bought over 3 million shares Wednesday under its buyback programme, raising treasury stock to nearly 752 million shares. Shares rose about 0.5% in early London trading. Oil prices slipped Thursday, with Brent at $64.96 a barrel and U.S. crude at $60.43. Earlier this month, BP moved 145 million treasury shares into employee schemes, adjusting total voting rights to 15.76 billion.
22 January 2026
··
BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”

BT shares rose about 2.3% in early London trading after Openreach expanded its copper "stop sell" programme by 132 exchanges, affecting 1.23 million premises. UBS kept its “sell” rating and 140p target, warning of pricing and investment risks. Openreach aims to move all providers to digital phone lines by January 2027. BT will report third-quarter results on February 5.
22 January 2026
··
Hang Seng wobbles, then closes higher as Hong Kong inflation ticks up and Trump cools tariff talk

Hang Seng wobbles, then closes higher as Hong Kong inflation ticks up and Trump cools tariff talk

The Hang Seng Index closed up 44 points at 26,629 on Thursday after a volatile session, with turnover at HK$234.86 billion. Baidu hit a record high, Pop Mart surged, while China Life and Ping An fell. December consumer prices in Hong Kong rose 1.4% year-on-year, with underlying inflation at 1.2%. Mainland insurers lagged as tech stocks and financials led early gains.
22 January 2026
·
1 … 237 238 239 240 241 … 1,174

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop